Chester County News and Community Website
WAYNE, PA — Teleflex Incorporated (NYSE:TFX) recently announced that new real-world healthcare claims data reveal that the risk of return procedures is lowest after treatment with the UroLift® System among the …
Read More
MALVERN, PA — Representative Chrissy Houlahan (D-PA) on Wednesday joined Novocure leadership to tour their Malvern facility and learn more about their vital work. There, she heard about their mission …
Read More
DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) announced the publication this week of results from the Company’s open-label Phase 2 BELIEVE (Open Label Study to Assess the Safety and Efficacy …
Read More
MALVERN, PA — HMP Global recently announced world-renowned fetal pediatric surgeon Oluyinka Olutoye, MD, PhD will deliver the Keynote Address during the Symposium on Advanced Wound Care (SAWC Fall), taking …
Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) this week announced the publication of clinical data for the UroLift® System in the peer-reviewed journal Prostate Cancer and Prostatic Disease. This study explains the …
Read More
PLYMOUTH MEETING, PA — Among all patients with neuroendocrine tumors (NETs), the risk of dying of cancer was higher than that of dying of other causes, but mortality varies by primary …
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration recently approved the MicroTransponder Vivistim Paired VNS System (Vivistim System), a first-of-its-kind, drug-free rehabilitation system intended to treat moderate to severe …
Read More
WEST READING, PA — Tower Health announced that its Tower Health Transplant Institute (THTI) and related transplant Nephrology and Hepatology practices will transition to Penn Medicine. THTI’s kidney and liver …
Read More
RADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) this week announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 …
Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced three upcoming poster presentations on its OviTex Reinforced Tissue Matrix portfolio. Data demonstrating the effectiveness of OviTex in a variety of …
Read More